Factors to Consider When Selecting T Cell-Directed Therapies for Myeloma
September 26th 2024Rahul Banerjee, MD, FACP, discussed his presentation at the International Myeloma Society 2024 Annual Meeting on available T cell-directed therapies for myeloma treatment, including CAR T-cell therapies and bispecific antibodies.
Watch
Study: Most Pregnancies Following alloHCT Were Spontaneous and Had Favorable Outcomes
September 25th 2024About 72% of the observed pregnancies after allogeneic hematopoietic cell transplantation occurred spontaneously, whereas remaining pregnancies were a result of assisted reproductive activities.
Read More
Dato-DXd Did Not Achieve Statistically Significant OS in Patients With Breast Cancer
September 24th 2024Compared with chemotherapy, datopotamab deruxtecan (Dato-DXd) did not achieve a statistically significant overall survival (OS) in patients with inoperable or metastatic HR+/HER2-low or negative breast cancer.
Read More